Enovis Corporation EBITDA Margin 2010-2024 | ENOV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Enovis Corporation (ENOV) over the last 10 years. The current EBITDA margin for Enovis Corporation as of September 30, 2024 is .
| Enovis Corporation EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-09-30 |
$2.00B |
$0.15B |
7.50% |
| 2024-06-30 |
$1.91B |
$0.15B |
7.63% |
| 2024-03-31 |
$1.82B |
$0.16B |
8.97% |
| 2023-12-31 |
$1.71B |
$0.15B |
8.90% |
| 2023-09-30 |
$1.66B |
$0.13B |
7.52% |
| 2023-06-30 |
$1.63B |
$0.12B |
7.49% |
| 2023-03-31 |
$1.59B |
$0.14B |
8.78% |
| 2022-12-31 |
$1.56B |
$0.15B |
9.47% |
| 2022-09-30 |
$0.99B |
$0.09B |
9.34% |
| 2022-06-30 |
$0.96B |
$0.11B |
11.76% |
| 2022-03-31 |
$0.92B |
$0.11B |
12.15% |
| 2021-12-31 |
$1.43B |
$0.20B |
14.10% |
| 2021-09-30 |
$0.47B |
$0.13B |
27.06% |
| 2021-06-30 |
$0.92B |
$0.20B |
21.55% |
| 2021-03-31 |
$1.18B |
$0.20B |
16.82% |
| 2020-12-31 |
$1.12B |
$0.18B |
16.07% |
| 2020-09-30 |
$3.13B |
$0.42B |
13.48% |
| 2020-06-30 |
$3.17B |
$0.44B |
13.78% |
| 2020-03-31 |
$3.46B |
$0.50B |
14.36% |
| 2019-12-31 |
$3.33B |
$0.44B |
13.19% |
| 2019-09-30 |
$2.67B |
$0.35B |
13.09% |
| 2019-06-30 |
$2.34B |
$0.29B |
12.16% |
| 2019-03-31 |
$2.00B |
$0.25B |
12.42% |
| 2018-12-31 |
$2.19B |
$0.30B |
13.68% |
| 2018-09-30 |
$1.48B |
$0.40B |
26.95% |
| 2018-06-30 |
$1.80B |
$0.43B |
24.03% |
| 2018-03-31 |
$2.09B |
$0.46B |
22.01% |
| 2017-12-31 |
$1.94B |
$0.45B |
23.32% |
| 2017-09-30 |
$3.01B |
$0.40B |
13.28% |
| 2017-06-30 |
$2.93B |
$0.38B |
13.09% |
| 2017-03-31 |
$3.04B |
$0.39B |
12.68% |
| 2016-12-31 |
$3.19B |
$0.38B |
11.93% |
| 2016-09-30 |
$3.13B |
$0.38B |
12.04% |
| 2016-06-30 |
$3.33B |
$0.37B |
11.10% |
| 2016-03-31 |
$3.40B |
$0.39B |
11.53% |
| 2015-12-31 |
$3.43B |
$0.42B |
12.23% |
| 2015-09-30 |
$4.11B |
$0.48B |
11.75% |
| 2015-06-30 |
$4.31B |
$0.56B |
13.01% |
| 2015-03-31 |
$4.48B |
$0.58B |
12.95% |
| 2014-12-31 |
$4.62B |
$0.59B |
12.65% |
| 2014-09-30 |
$4.59B |
$0.58B |
12.73% |
| 2014-06-30 |
$4.44B |
$0.56B |
12.53% |
| 2014-03-31 |
$4.31B |
$0.54B |
12.56% |
| 2013-12-31 |
$4.21B |
$0.53B |
12.48% |
| 2013-09-30 |
$4.06B |
$0.46B |
11.25% |
| 2013-06-30 |
$4.00B |
$0.42B |
10.52% |
| 2013-03-31 |
$3.97B |
$0.39B |
9.76% |
| 2012-12-31 |
$3.91B |
$0.32B |
8.28% |
| 2012-09-30 |
$3.06B |
$0.24B |
7.73% |
| 2012-06-30 |
$2.28B |
$0.15B |
6.58% |
| 2012-03-31 |
$1.42B |
$0.07B |
4.93% |
| 2011-12-31 |
$0.69B |
$0.05B |
7.06% |
| 2011-09-30 |
$0.68B |
$0.08B |
11.27% |
| 2011-06-30 |
$0.65B |
$0.08B |
12.25% |
| 2011-03-31 |
$0.58B |
$0.06B |
11.02% |
| 2010-12-31 |
$0.54B |
$0.05B |
9.59% |
| 2010-09-30 |
$0.51B |
$0.04B |
8.10% |
| 2010-06-30 |
$0.50B |
$0.04B |
8.35% |
| 2010-03-31 |
$0.51B |
$0.05B |
8.84% |
| 2009-12-31 |
$0.53B |
$0.06B |
10.67% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MEDICAL INFO SYS |
$2.428B |
$1.707B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Veeva Systems Inc. (VEEV) |
US |
$36.657B |
54.02 |
| Hims & Hers Health, Inc. (HIMS) |
US |
$10.767B |
273.78 |
| Tempus AI, Inc. (TEM) |
US |
$10.720B |
0.00 |
| Inspire Medical Systems, Inc. (INSP) |
US |
$5.261B |
102.50 |
| iRhythm Technologies (IRTC) |
US |
$3.752B |
0.00 |
| Privia Health Group, Inc. (PRVA) |
US |
$2.942B |
245.20 |
| Clover Health Investments, Corp. (CLOV) |
US |
$2.205B |
0.00 |
| Azenta, Inc. (AZTA) |
US |
$2.045B |
95.21 |
| Omnicell, Inc. (OMCL) |
US |
$1.840B |
40.12 |
| Schrodinger, Inc. (SDGR) |
US |
$1.650B |
0.00 |
| Phreesia, Inc. (PHR) |
US |
$1.640B |
0.00 |
| 10x Genomics (TXG) |
US |
$1.333B |
0.00 |
| Butterfly Network, Inc. (BFLY) |
US |
$0.916B |
0.00 |
| Talkspace, Inc. (TALK) |
US |
$0.508B |
300.50 |
| Fulgent Genetics, Inc. (FLGT) |
US |
$0.503B |
0.00 |
| Standard BioTools Inc. (LAB) |
US |
$0.484B |
0.00 |
| TruBridge, Inc. (TBRG) |
US |
$0.422B |
122.87 |
| Pulmonx Corporation (LUNG) |
US |
$0.354B |
0.00 |
| Nyxoah SA (NYXH) |
BE |
$0.352B |
0.00 |
| Health Catalyst, Inc. (HCAT) |
US |
$0.318B |
0.00 |
| SOPHiA GENETICS SA (SOPH) |
CH |
$0.266B |
0.00 |
| American Well Corporation (AMWL) |
US |
$0.183B |
0.00 |
| EUDA Health Holdings Limited (EUDA) |
SG |
$0.098B |
0.00 |
| MDxHealth SA (MDXH) |
BE |
$0.088B |
0.00 |
| P3 Health Partners Inc. (PIII) |
US |
$0.075B |
0.00 |
| 111, Inc. Sponsored ADR (YI) |
CN |
$0.072B |
0.00 |
| CareCloud, Inc. (CCLD) |
US |
$0.058B |
0.00 |
| HeartBeam, Inc. (BEAT) |
US |
$0.055B |
0.00 |
| Outset Medical, Inc. (OM) |
US |
$0.047B |
0.00 |
| Zepp Health Corporation Sponsored ADR (ZEPP) |
CN |
$0.045B |
0.00 |
| SHL Telemedicine Ltd. Unsponsored ADR (SHLT) |
IL |
$0.038B |
0.00 |
| Zhongchao Inc. (ZCMD) |
CN |
$0.035B |
0.00 |
| Movano Inc. (MOVE) |
US |
$0.033B |
0.00 |
| Bullfrog AI Holdings Inc. (BFRG) |
US |
$0.025B |
0.00 |
| MSP Recovery, Inc. (MSPR) |
US |
$0.016B |
0.00 |
| Streamline Health Solutions, Inc. (STRM) |
US |
$0.015B |
0.00 |
| Precipio, Inc. (PRPO) |
US |
$0.015B |
0.00 |
| ImmunoPrecise Antibodies Ltd. (IPA) |
CA |
$0.012B |
0.00 |
| Mobile-health Network Solutions (MNDR) |
SG |
$0.012B |
0.00 |
| Strata Skin Sciences, Inc. (SSKN) |
US |
$0.011B |
0.00 |
| Predictive Oncology Inc. (POAI) |
US |
$0.010B |
0.00 |
| Syra Health Corp. (SYRA) |
US |
$0.005B |
0.00 |
| Tivic Health Systems, Inc. (TIVC) |
US |
$0.004B |
0.00 |
| HeartSciences Inc. (HSCS) |
US |
$0.004B |
0.00 |
| Healthcare Triangle, Inc. (HCTI) |
US |
$0.003B |
0.00 |
| Future Health ESG Corp. (FHLT) |
US |
$0.000B |
0.00 |
